Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jijia International Medical Technology, also known as Jijia Medical Group, is a Beijing-based healthcare company specializing in integrated medical solutions and global health infrastructure. Established in 2016, the company provides turn-key hospital projects, medical equipment supply, and medical engineering services across more than 50 countries. A significant recent initiative includes a $37 million partnership with Zambia's Industrial Development Corporation to establish Africa's first cholera vaccine manufacturing facility. Jijia also operates in the health supplement and medical device sectors through its international subsidiaries in Hong Kong and Singapore.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JIJIA International.